Caption Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.5M Buy
247,000
+17,000
+7% +$3.81M 0.33% 61
2025
Q4
$49M Buy
230,000
+124,400
+118% +$25.7M 0.34% 64
2025
Q3
$21M Buy
105,600
+50,600
+92% +$9.44M 0.16% 136
2025
Q2
$9.49M Buy
+55,000
New +$8.96M 0.11% 218
2024
Q4
Sell
-32,500
Closed -$4.85M 1448
2024
Q3
$4.85M Buy
+32,500
New +$4.39M 0.08% 303
2023
Q4
Sell
-26,000
Closed -$2.43M 1323
2023
Q3
$2.43M Sell
26,000
-117,200
-82% -$11M 0.04% 529
2023
Q2
$12.8M Sell
143,200
-316,400
-69% -$27.5M 0.23% 110
2023
Q1
$49.3M Buy
459,600
+300,400
+189% +$34.4M 0.95% 11
2022
Q4
$19.4M Sell
159,200
-488,800
-75% -$56.8M 0.3% 69
2022
Q3
$66.9M Buy
+648,000
New +$61.4M 0.92% 10
2022
Q1
Sell
-20,000
Closed -$2.69M 1444
2021
Q4
$2.69M Hold
20,000
0.03% 679
2021
Q3
$3.19M Buy
20,000
+7,000
+54% +$958K 0.04% 600
2021
Q2
$1.71M Sell
13,000
-7,000
-35% -$933K 0.02% 727
2021
Q1
$2.58M Buy
+20,000
New +$3.04M 0.06% 441
2020
Q1
Sell
-62,100
Closed -$8.64M 852
2019
Q4
$8.64M Buy
+62,100
New +$6.9M 0.29% 78
2019
Q3
Sell
-20,000
Closed -$2.3M 695
2019
Q2
$2.3M Sell
20,000
-133,800
-87% -$16M 0.12% 230
2019
Q1
$18.1M Buy
+153,800
New +$13.5M 1% 12

Other funds holding ASND

Caption Management's ASND Position: Q3 2025 in Review

Caption Management sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 6,499 shares — an estimated $1.21M sold.

Caption Management first reported a position in ASND in Q3 2019 and held it in 10 quarters. The position peaked at $6.25M in Q4 2024. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • Caption Management reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • Caption Management sold 6,499 Ascendis Pharma A/S shares in Q3 2025, an estimated $1.21M.
  • Caption Management first reported a position in Ascendis Pharma A/S in Q3 2019 and held it in 10 quarters.
  • Caption Management's Ascendis Pharma A/S position peaked at $6.25M in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.